For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

PT-141 (Bremelanotide) Sourcing Review

A PT-141 inquiry should identify whether it concerns a specific bremelanotide medicine or another preparation. Ingredient naming alone does not establish product approval.

Reference variants

Add PT-141 to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 189691-06-3
    $15.53/vial$12.42/vial at 1,000+ vials of this item
    vials, packs of 10
  • 15mgSpray bottleCAS 189691-06-3
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Review your order request · Compare the full catalog

Resolve the name against the exact product

PT-141 is used in marketing as a name for bremelanotide. Require a complete product identity, manufacturer and formulation rather than relying on the abbreviated label.

Respect the limits of product-specific evidence

Review the labeled population and indication for any approved medicine being discussed. Do not generalize those findings to other formulations, combinations or broader sexual-health claims.

Before a sourcing inquiry

For PT-141 (Bremelanotide), provide the exact substance or finished-product identity, intended transaction, facility type and destination state. Do not send patient information. A qualified reviewer must confirm the applicable pathway before purchasing.

  • Obtain product- and lot-specific identity and quality records before accepting material.
  • Verify storage, shipping and dating against the actual preparation, not a generic catalog range.
  • Request written confirmation of availability and terms; this page does not confirm stock, strength, price or supply eligibility.

We do not currently have verified COAs available to publish. No purity, sterility or lot-release result is established by this page.

Purchasing questions

Is every PT-141 preparation an approved bremelanotide medicine?

No. Product approval does not apply to every preparation containing the ingredient. Verify the exact medicine or proposed compounding pathway separately.

Identify the actual bremelanotide preparation

An abbreviated PT-141 listing does not establish equivalence to a labeled bremelanotide medicine. The vial and spray formats should not inherit each other's evidence or an approved product's indication.

Documentation to request

Request exact formulation, manufacturer and labeling, then compare the intended product with the regulatory record cited by the supplier.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Product-by-product review for hormone clinics. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. A compounded preparation is not FDA-approved. This reference is not medical or legal advice and does not establish a lawful supply route.

Ask about the review requirements

Ask what information is needed to assess a PT-141 (Bremelanotide) inquiry. An inquiry is not confirmation that the product can be supplied.

Discuss sourcing requirements
Call Apply for Wholesale